6-39856354-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000274867.9(DAAM2):c.52G>A(p.Gly18Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00474 in 1,553,092 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0035 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0049 ( 22 hom. )
Consequence
DAAM2
ENST00000274867.9 missense
ENST00000274867.9 missense
Scores
6
12
Clinical Significance
Conservation
PhyloP100: 3.91
Genes affected
DAAM2 (HGNC:18143): (dishevelled associated activator of morphogenesis 2) Predicted to enable actin binding activity and small GTPase binding activity. Predicted to be involved in nervous system development and regulation of Wnt signaling pathway. Predicted to act upstream of or within determination of left/right symmetry. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009129673).
BP6
Variant 6-39856354-G-A is Benign according to our data. Variant chr6-39856354-G-A is described in ClinVar as [Benign]. Clinvar id is 771395.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DAAM2 | NM_001201427.2 | c.52G>A | p.Gly18Arg | missense_variant | 2/25 | ENST00000274867.9 | NP_001188356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DAAM2 | ENST00000274867.9 | c.52G>A | p.Gly18Arg | missense_variant | 2/25 | 1 | NM_001201427.2 | ENSP00000274867 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00349 AC: 531AN: 152196Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
531
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00408 AC: 686AN: 167966Hom.: 2 AF XY: 0.00403 AC XY: 362AN XY: 89780
GnomAD3 exomes
AF:
AC:
686
AN:
167966
Hom.:
AF XY:
AC XY:
362
AN XY:
89780
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00487 AC: 6826AN: 1400778Hom.: 22 Cov.: 31 AF XY: 0.00480 AC XY: 3321AN XY: 692278
GnomAD4 exome
AF:
AC:
6826
AN:
1400778
Hom.:
Cov.:
31
AF XY:
AC XY:
3321
AN XY:
692278
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00349 AC: 531AN: 152314Hom.: 3 Cov.: 32 AF XY: 0.00325 AC XY: 242AN XY: 74484
GnomAD4 genome
AF:
AC:
531
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
242
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
22
ALSPAC
AF:
AC:
28
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
37
ExAC
AF:
AC:
395
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
DAAM2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 19, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 07, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;L;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;N;N
REVEL
Uncertain
Sift
Benign
.;T;T;T;T
Sift4G
Benign
T;T;T;T;T
Polyphen
0.014, 1.0
.;B;.;B;D
Vest4
MutPred
Gain of phosphorylation at S20 (P = 0.1041);Gain of phosphorylation at S20 (P = 0.1041);Gain of phosphorylation at S20 (P = 0.1041);Gain of phosphorylation at S20 (P = 0.1041);Gain of phosphorylation at S20 (P = 0.1041);
MVP
0.71
MPC
0.51
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at